FRIEDMAN PAUL A sold MDGL
August 13, 2025 · Form 4 insider transaction
FRIEDMAN PAUL A sold 6,788 shares of Madrigal Pharmaceuticals, Inc. at $368.34 per share, a transaction worth $2.50M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
6,788
Price
$368.34
Total value
$2.50M
InsiderFRIEDMAN PAUL A
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateAugust 13, 2025
Filing dateAugust 13, 2025
Shares owned after283,040
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025.; The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $367.90 to $368.89, inclusive.